MEDPLARGE

Medpace Holdings, Inc.

HealthcareMedical - Diagnostics & Research
$546.29
$0.18(-3.33%)
52W$306.70
$628.92
Updated Jul 8, 02:00 AM
RSI81
RS Rating72/99
Beta0.95
Volatility70%
F-Score6/9
Mkt Cap$15.6B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Medpace Holdings, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 72), indicating performance broadly in line with the market. Earnings growth of 17% provides fundamental context to the price action. However, with RSI at 81, the stock is extended and may be prone to a short-term pullback.

Relative Strength
72
out of 99
Average
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.95
vs S&P 500
MARKET
52W Position
74%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$455.94
50 SMA > 100 SMA$462.59
100 SMA > 150 SMA$500.37
150 SMA > 200 SMA$514.40

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$497.25+9.86%ABOVE
50 SMA$455.94+19.82%ABOVE
100 SMA$462.59+18.09%ABOVE
150 SMA$500.37+9.18%ABOVE
200 SMA$514.40+6.20%ABOVE

Price Performance

1D-3.3%
1W+3.2%
1M+19.3%
3M+7.4%
6M-10.9%
YTD-4.3%
1Y+71.3%
3Y+32.4%
52-Week Trading Range74% from low
$546.29
52W Low$306.70
52W High$628.92

Technical Indicators

RSI (14)OVERBOUGHT
81.3
305070
Setup ScoreCOOL
4/10
Base depth: 35.7%

Risk Profile

Beta
0.95
52W Vol
70%
ATR
$18.71
Max DD (1Y)
-37%

Volume Analysis

Today
343.4K
50D Avg
292.2K
Vol Ratio
1.18x
Liquidity
LIQUID

Earnings Momentum

Q2'25+13%
$3.10
Q3'25+29%
$3.87
Q4'25+27%
$4.67
Q1'26+17%
$4.28
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+21.56%
5 Years:+22.27%
3 Years:+20.12%
TTM:+24.19%

Compounded Profit Growth

10 Years:
5 Years:+31.81%
3 Years:+28.04%
TTM:+21.53%

Stock Price CAGR

10 Years:+34.70%
5 Years:+25.11%
3 Years:+32.37%
1 Year:+71.30%

Return on Equity

10Y Avg:30.3%
5Y Avg:49.2%
3Y Avg:62.8%
Last Year:120.9%

Key Metrics

Market Cap$15.6B
Gross Margin30.1%
Net Margin17.8%
Piotroski F-Score6/9

Frequently Asked Questions

Is MEDP in an uptrend right now?

MEDP has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is MEDP overbought or oversold?

MEDP's RSI (14) is 81. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is MEDP outperforming the market?

MEDP has a Relative Strength (RS) Rating of 72 out of 99. MEDP is performing about average compared to the market.

Where is MEDP in its 52-week range?

MEDP is trading at $546.29, which is 87% of its 52-week high ($628.92) and 74% above its 52-week low ($306.70).

How volatile is MEDP?

MEDP has a Beta of 0.95 and 52-week volatility of 70%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.